4DMedical Ltd Ordinary Shares 4DX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.60
- Day Range
- A$0.59–0.62
- 52-Week Range
- A$0.45–1.27
- Bid/Ask
- A$0.59 / A$0.61
- Market Cap
- A$238.74 Mil
- Volume/Avg
- 451,246 / 743,680
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 260.57
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.4dmedical.com
Comparables
Valuation
|
Metric
|
4DX
|
688607
|
RXST
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 2.62 | 1.23 | 12.24 |
Price/Sales | 260.57 | 4.31 | 21.01 |
Price/Cash Flow | — | 85.68 | — |
Price/Earnings
4DX
688607
RXST
Financial Strength
|
Metric
|
4DX
|
688607
|
RXST
|
|---|---|---|---|
Quick Ratio | 1.44 | 8.76 | 7.05 |
Current Ratio | 1.82 | 10.33 | 8.06 |
Interest Coverage | −118.80 | −12.85 | −15.68 |
Quick Ratio
4DX
688607
RXST
Profitability
|
Metric
|
4DX
|
688607
|
RXST
|
|---|---|---|---|
Return on Assets (Normalized) | −29.43% | −1.66% | −17.04% |
Return on Equity (Normalized) | −43.16% | −1.79% | −21.78% |
Return on Invested Capital (Normalized) | −41.34% | −1.92% | −20.20% |
Return on Assets
4DX
688607
RXST
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Qpqcnjjl | Gtnjdgx | $182.7 Bil | |
SYK
| Stryker Corp | Thbrwrkbq | Qwb | $124.6 Bil | |
MDT
| Medtronic PLC | Zqkgmbsc | Dxxgvz | $105.2 Bil | |
BSX
| Boston Scientific Corp | Xfndvvdx | Zfqvbwj | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Zylcwgqyj | Qpnztd | $52.0 Bil | |
DXCM
| DexCom Inc | Fmpmyshthq | Rxnkn | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Tcxxvnlhf | Ztp | $24.5 Bil | |
ALGN
| Align Technology Inc | Bqkzhdnyk | Gngfp | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Gnzwlxtl | Krzrlx | $18.3 Bil | |
PODD
| Insulet Corp | Hzykbrpvc | Lkbbybl | $11.6 Bil |